Management of the clinically node-negative axilla in primary and locally recurrent breast cancer

Ashley C. McGinity, Meeghan A. Lautner, Ismail Jatoi

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

For patients with primary breast cancer, nodal status remains a key determinant for overall prognosis. Sentinel lymph node biopsy (SLNB) has become standard care for staging patients who have clinically node-negative disease. However, a new dilemma has arisen: how to manage the clinically negative axilla in patients with ipsilateral breast tumor recurrences (IBTRs). Are outcomes in these patients improved with repeat SLNB? Although observational studies suggest SLNB is feasible in patients with IBTR and a clinically node-negative axilla, the overall impact on morality and local recurrence is not yet known as no randomized trials have addressed this issue.

Original languageEnglish (US)
Pages (from-to)463-471
Number of pages9
JournalSurgical Oncology Clinics of North America
Volume23
Issue number3
DOIs
StatePublished - Jul 2014

Keywords

  • Axilla
  • Breast cancer
  • Recurrence
  • Sentinel lymph node

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Management of the clinically node-negative axilla in primary and locally recurrent breast cancer'. Together they form a unique fingerprint.

Cite this